Carmat SA (EPA:ALCAR)

Market Cap	51.22M
Revenue (ttm)	6.93M
Net Income (ttm)	-53.35M
Shares Out	58.81M
EPS (ttm)	-1.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,676
Average Volume	143,473
Open	0.8850
Previous Close	0.8710
Day's Range	0.8700 - 0.8870
52-Week Range	0.6930 - 4.4000
Beta	1.52
RSI	51.35
Earnings Date	Apr 30, 2025

About Carmat

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 182
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALCAR

Financial Performance

In 2023, Carmat's revenue was 3.84 million, an increase of 704.40% compared to the previous year's 477,000. Losses were -53.87 million, 0.35% more than in 2022.